- Home
- Publications
- Publication Search
- Publication Details
Title
Hypocretins (orexins): The ultimate translational neuropeptides
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-19
DOI
10.1111/joim.13406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Orexins (hypocretins): The intersection between homeostatic and hedonic feeding
- (2021) Muthmainah Muthmainah et al. JOURNAL OF NEUROCHEMISTRY
- Manipulation of rapid eye movement sleep via orexin and GABAA receptor modulators differentially affects fear extinction in mice: effect of stable versus disrupted circadian rhythm
- (2021) Jacob W Clark et al. SLEEP
- Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study
- (2021) Adam Savitz et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
- (2020) W. Joseph Herring et al. Alzheimers & Dementia
- Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
- (2020) Yves Dauvilliers et al. ANNALS OF NEUROLOGY
- First ‐ in ‐ man study with ACT ‐ 539313, a novel selective orexin‐1 receptor antagonist
- (2020) Priska Kaufmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of the Selective Orexin‐1 Receptor Antagonist ACT‐539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects
- (2020) Benjamin Berger et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Safety of Lemborexant Versus Placebo and Zolpidem: Effects on Auditory Awakening Threshold, Postural Stability, and Cognitive Performance in Healthy Older Subjects in the Middle of the Night and Upon Morning Awakening
- (2020) Patricia Murphy et al. Journal of Clinical Sleep Medicine
- Suvorexant Ameliorates Cognitive Impairments and Pathology in APP/PS1 Transgenic Mice
- (2020) Fang Zhou et al. NEUROBIOLOGY OF AGING
- Effects of Intranasal Orexin-A (Hypocretin-1) Administration on Neuronal Activation, Neurochemistry, and Attention in Aged Rats
- (2020) Coleman B. Calva et al. Frontiers in Aging Neuroscience
- Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder
- (2020) Shlomi Cohen et al. Translational Psychiatry
- Discovery of ORN0829, a potent dual orexin 1/2 receptor antagonist for the treatment of insomnia
- (2020) Aya Futamura et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis
- (2020) Matthias Boentert Current Neurology and Neuroscience Reports
- Orexin signaling in GABAergic lateral habenula neurons modulates aggressive behavior in male mice
- (2020) Meghan E. Flanigan et al. NATURE NEUROSCIENCE
- Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder
- (2020) Gary Zammit et al. NEUROLOGY
- The hypocretin (orexin) system: from a neural circuitry perspective
- (2020) Shi-Bin Li et al. NEUROPHARMACOLOGY
- 0521 Daridorexant (ACT-541468), A Dual Orexin Receptor Antagonist for the Treatment of Insomnia Disorder: Double Blind, Randomized, Phase 3 Studies for Efficacy and Safety in Adult and Elderly Patients
- (2020) G Zammit et al. SLEEP
- Effects of orexin receptor antagonism on human sleep architecture: A systematic review
- (2020) Jacob W. Clark et al. SLEEP MEDICINE REVIEWS
- Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793
- (2020) Cathy Préville et al. ACS Medicinal Chemistry Letters
- 20 Years of Medicinal Chemistry – Always Look at the Bright Side (of Life)
- (2020) Christoph Boss CHIMIA
- Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder
- (2020) Bojan Lalovic et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Suvorexant for the prevention of delirium
- (2020) Shu Xu et al. MEDICINE
- Orchestrating Opiate-Associated Memories in Thalamic Circuits
- (2020) Piper C. Keyes et al. NEURON
- Structure-based development of a subtype-selective orexin 1 receptor antagonist
- (2020) Jan Hellmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
- (2020) Mikko Kärppä et al. SLEEP
- Sleep in Parkinson's disease: A systematic review and meta-analysis of polysomnographic findings
- (2020) Ye Zhang et al. SLEEP MEDICINE REVIEWS
- The quest for the best dual orexin receptor antagonist (daridorexant) for the treatment of insomnia disorders
- (2020) Christoph Boss et al. ChemMedChem
- Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
- (2020) Giacomo Salvadore et al. Translational Psychiatry
- Hypothalamic circuitry underlying stress-induced insomnia and peripheral immunosuppression
- (2020) Shi-Bin Li et al. Science Advances
- Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510
- (2020) Ryan J. Keenan et al. JOURNAL OF ALZHEIMERS DISEASE
- Multiple-dose clinical pharmacology of the selective orexin-1 receptor antagonist ACT-539313
- (2020) Priska Kaufmann et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Orexin/hypocretin receptor, Orx1, gene variants are associated with major depressive disorder
- (2019) Mujgan Cengiz et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia
- (2019) Sander Brooks et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder
- (2019) Saliha Baykal et al. NEUROLOGICAL SCIENCES
- Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes
- (2019) Michael G. Gottschalk et al. Translational Psychiatry
- HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy
- (2019) Noriaki Sakai et al. Scientific Reports
- Orexin/hypocretin receptor gene (HCRTR1) variation is associated with aggressive behaviour
- (2019) Jaanus Harro et al. NEUROPHARMACOLOGY
- Activation of orexinergic and histaminergic pathway involved in therapeutic effect of histamine H4 receptor antagonist against cisplatin-induced anorexia in mice
- (2019) Kouichi Yamamoto et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Sleep modulates haematopoiesis and protects against atherosclerosis
- (2019) Cameron S. McAlpine et al. NATURE
- Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: The SUPER‐1 study
- (2019) Kazuomi Kario et al. Journal of Clinical Hypertension
- Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect
- (2019) Steven J. Simmons et al. BRAIN RESEARCH
- Sleep Disorders in Huntington’s Disease
- (2019) Radoslawa Herzog–Krzywoszanska et al. Frontiers in Psychiatry
- Multiple-dose clinical pharmacology of ACT-541468, a novel dual orexin receptor antagonist, following repeated-dose morning and evening administration
- (2019) Clemens Muehlan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Molecular Mechanisms of Cancer-Induced Sleep Disruption
- (2019) William H. Walker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa
- (2019) Trevor Steward et al. Scientific Reports
- The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
- (2019) Kasper Recourt et al. Translational Psychiatry
- Clinical pharmacology of the dual orexin receptor antagonist ACT-541468 in elderly subjects: Exploration of pharmacokinetics, pharmacodynamics and tolerability following single-dose morning and repeated-dose evening administration
- (2019) Clemens Muehlan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Distinct effects of orexin receptor antagonist and GABAA agonist on sleep and physical/cognitive functions after forced awakening
- (2019) Jaehoon Seol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial
- (2019) Erin J. Campbell et al. BRAIN RESEARCH
- TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice
- (2019) Hiroshi Yukitake et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Results of a phase 1, 4-period crossover, placebo-controlled, randomized, single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-925, a novel orexin 2 receptor agonist, in sleep-deprived healthy adults, utilizing modafinil as an active comparator
- (2019) R. Evans et al. SLEEP MEDICINE
- A novel, orally available orexin 2 receptor-selective agonist, tak-994, ameliorates narcolepsy-like symptoms in narcolepsy mouse models
- (2019) H. Kimura et al. SLEEP MEDICINE
- Nonpeptide Orexin-2 Receptor Agonist Attenuates Morphine-induced Sedative Effects in Rats
- (2018) Satoshi Toyama et al. ANESTHESIOLOGY
- The Gamma-Aminobutyric Acid B Receptor in Depression and Reward
- (2018) Laura H. Jacobson et al. BIOLOGICAL PSYCHIATRY
- A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Cancer
- (2018) Jeremy C. Borniger et al. Cell Metabolism
- An overview of hypocretin based therapy in narcolepsy
- (2018) Shinichi Takenoshita et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity
- (2018) Peter De Boer et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Orexin 1 and orexin 2 receptor antagonism in the basolateral amygdala modulate long-term potentiation of the population spike in the perforant path-dentate gyrus-evoked field potential in rats
- (2018) Motahareh Rouhi Ardeshiri et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Orexin knockout mice exhibit impaired spatial working memory
- (2018) Ruozhi Dang et al. NEUROSCIENCE LETTERS
- Effect of orexin-A in the arcuate nucleus on cisplatin-induced gastric side effects in rats
- (2018) Feifei Guo et al. NEUROSCIENCE RESEARCH
- Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy
- (2018) Mahesh K. Kaushik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Orexin A Differentially Influences the Extinction Retention of Recent and Remote Fear Memory
- (2018) Le Shi et al. Frontiers in Neuroscience
- Sympathetic, Metabolic Adaptations, and Oxidative Stress in Autism Spectrum Disorders: How Far From Physiology?
- (2018) Antonietta Messina et al. Frontiers in Physiology
- Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior
- (2018) Jessica R. Barson BRAIN RESEARCH
- A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
- (2018) Erin J. Campbell et al. BRAIN RESEARCH
- Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction
- (2018) Coleman B. Calva et al. BRAIN RESEARCH
- Therapeutics development for addiction: Orexin-1 receptor antagonists
- (2018) David A. Perrey et al. BRAIN RESEARCH
- An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics
- (2018) Kayla Janto et al. Journal of Clinical Sleep Medicine
- Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects
- (2018) Peter D van der Ark et al. JOURNAL OF PSYCHOPHARMACOLOGY
- CSF pro-orexin and amyloid-β38 expression in Alzheimer’s disease and frontotemporal dementia
- (2018) Wendy E. Heywood et al. NEUROBIOLOGY OF AGING
- Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression
- (2018) Clarissa D. Staton et al. NEUROPHARMACOLOGY
- Optical probing of orexin/hypocretin receptor antagonists
- (2018) Shi-Bin Li et al. SLEEP
- Orexin as a modulator of fear-related behavior: Hypothalamic control of noradrenaline circuit
- (2018) Shingo Soya et al. BRAIN RESEARCH
- The potential role of the orexin reward system in future treatments for opioid drug abuse
- (2018) Shahram Zarrabian et al. BRAIN RESEARCH
- Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy
- (2018) Cliff H. Summers et al. BRAIN RESEARCH
- Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa
- (2018) Susan L. McElroy et al. CNS DRUGS
- Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
- (2018) W. Joseph Herring et al. JOURNAL OF SLEEP RESEARCH
- The glymphatic pathway in neurological disorders
- (2018) Martin Kaag Rasmussen et al. LANCET NEUROLOGY
- Dynamic salience processing in paraventricular thalamus gates associative learning
- (2018) Yingjie Zhu et al. SCIENCE
- On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
- (2018) Annemiek Vermeeren et al. SLEEP
- Orexin Depolarizes Central Amygdala Neurons via Orexin Receptor 1, Phospholipase C and Sodium-Calcium Exchanger and Modulates Conditioned Fear
- (2018) Erik T. Dustrude et al. Frontiers in Neuroscience
- Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
- (2017) Patricia Murphy et al. Journal of Clinical Sleep Medicine
- The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
- (2017) Alexander Treiber et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
- (2017) Carsten Theodor Beuckmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Orexin/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice
- (2017) Vijayakumar Mavanji et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency
- (2017) Marco Filardi et al. PLoS One
- Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
- (2017) Yoko Irukayama-Tomobe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypocretin (orexin) is critical in sustaining theta/gamma-rich waking behaviors that drive sleep need
- (2017) Anne Vassalli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference
- (2017) Jed Black et al. SLEEP MEDICINE
- Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research
- (2017) Jaden Brandt et al. Drugs in research & development
- Orexin modulates behavioral fear expression through the locus coeruleus
- (2017) Shingo Soya et al. Nature Communications
- Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
- (2017) Pascal Bonaventure et al. Frontiers in Pharmacology
- Decision Making in Narcolepsy with Cataplexy
- (2017) Sophie Bayard et al. SLEEP
- Synthesis of [11C]MK-1064 as a new PET radioligand for imaging of orexin-2 receptor
- (2016) Mingzhang Gao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities
- (2016) Stephen P. Andrews et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia
- (2016) Kathryn M. Connor et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials
- (2016) W. Joseph Herring et al. Journal of Clinical Sleep Medicine
- Possible neuronal mechanisms of sleep disturbances in patients with autism spectrum disorders and attention-deficit/hyperactivity disorder
- (2016) Jun Kohyama MEDICAL HYPOTHESES
- Cellular activation of hypothalamic hypocretin/orexin neurons facilitates short-term spatial memory in mice
- (2016) Teemu Aitta-aho et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Orexin A induces bidirectional modulation of synaptic plasticity: Inhibiting long-term potentiation and preventing depotentiation
- (2016) Guan-Ling Lu et al. NEUROPHARMACOLOGY
- Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study
- (2016) Thomas Roth et al. SLEEP
- Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys
- (2016) Pamela L. Tannenbaum et al. SLEEP
- Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data
- (2016) Ellen Snyder et al. SLEEP MEDICINE
- Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?
- (2016) Bryce A. Mander et al. TRENDS IN NEUROSCIENCES
- Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study
- (2016) Thomas Roth et al. SLEEP
- Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys
- (2016) Pamela L. Tannenbaum et al. SLEEP
- Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
- (2016) Anthony L. Gotter et al. Scientific Reports
- Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934)
- (2015) Christoph Boss et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate
- (2015) Michael A. Letavic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist
- (2015) Yu Yoshida et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists
- (2015) Takashi Nagahara et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of rapid eye movement sleep for amygdala-related memory processing
- (2015) L. Genzel et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems
- (2015) Gregory S Parks et al. NEUROPSYCHOPHARMACOLOGY
- Orexins and fear: implications for the treatment of anxiety disorders
- (2015) África Flores et al. TRENDS IN NEUROSCIENCES
- Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses
- (2015) Patricia Bonnavion et al. Nature Communications
- Assessment and management of behavioral and psychological symptoms of dementia
- (2015) H. C. Kales et al. BMJ-British Medical Journal
- Assessment and management of behavioral and psychological symptoms of dementia
- (2015) H. C. Kales et al. BMJ-British Medical Journal
- The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy
- (2014) Sara Lena Weinhold et al. BEHAVIOURAL BRAIN RESEARCH
- Orexin/hypocretin role in reward: implications for opioid and other addictions
- (2014) Corey Baimel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structure-Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT-462206: a Potent, Brain-Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist
- (2014) Christoph Boss et al. ChemMedChem
- Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant
- (2014) Matthias Hoch et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease
- (2014) Jee Hoon Roh et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
- (2014) David Michelson et al. LANCET NEUROLOGY
- The Hypocretin/Orexin System Mediates the Extinction of Fear Memories
- (2014) África Flores et al. NEUROPSYCHOPHARMACOLOGY
- Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects
- (2014) Junshui Ma et al. SLEEP
- Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
- (2014) Yves A. Dauvilliers et al. Frontiers in Aging Neuroscience
- Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs
- (2014) Pamela L. Tannenbaum et al. Frontiers in Behavioral Neuroscience
- Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
- (2014) Claudio Liguori et al. JAMA Neurology
- Suvorexant for the treatment of insomnia
- (2014) Laura H Jacobson et al. Expert Review of Clinical Pharmacology
- Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
- (2014) Christine Dugovic et al. Frontiers in Neuroscience
- The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
- (2014) Stephen R. Morairty et al. Frontiers in Neuroscience
- Food for thought: The role of appetitive peptides in age-related cognitive decline
- (2013) Jim R. Fadel et al. AGEING RESEARCH REVIEWS
- Toward an Understanding of Agonist Binding to Human Orexin-1 and Orexin-2 Receptors with G-Protein-Coupled Receptor Modeling and Site-Directed Mutagenesis
- (2013) Alexander Heifetz et al. BIOCHEMISTRY
- Lipid signaling cascades of orexin/hypocretin receptors
- (2013) Jyrki P. Kukkonen BIOCHIMIE
- Orexin/hypocretin receptor signalling cascades
- (2013) J P Kukkonen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Discovery of 5′′-Chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2′:5′,3′′-terpyridine-3′-carboxamide (MK-1064): A Selective Orexin 2 Receptor Antagonist (2-SORA) for the Treatment of Insomnia
- (2013) Anthony J. Roecker et al. ChemMedChem
- Hypocretin/Orexin Neurons Contribute to Hippocampus-Dependent Social Memory and Synaptic Plasticity in Mice
- (2013) L. Yang et al. JOURNAL OF NEUROSCIENCE
- Sleep and Alzheimer disease pathology—a bidirectional relationship
- (2013) Yo-El S. Ju et al. Nature Reviews Neurology
- Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
- (2013) Daniel Hoyer et al. NEUROPEPTIDES
- Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus
- (2013) R. M. Sears et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sleep Drives Metabolite Clearance from the Adult Brain
- (2013) L. Xie et al. SCIENCE
- Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
- (2013) J. M. Uslaner et al. Science Translational Medicine
- Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors
- (2013) Gabrielle E. Callander et al. Frontiers in Neuroscience
- The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome
- (2013) Michel A. Steiner et al. Frontiers in Pharmacology
- Sleep Disturbances as the Hallmark of PTSD: Where Are We Now?
- (2012) Anne Germain AMERICAN JOURNAL OF PSYCHIATRY
- Neuropeptides and Neuropeptide Receptors: Drug Targets, and Peptide and Non-Peptide Ligands: a Tribute to Prof.Dieter Seebach
- (2012) Daniel Hoyer et al. CHEMISTRY & BIODIVERSITY
- Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties
- (2012) Paul J. Coleman et al. ChemMedChem
- Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial
- (2012) P Hoever et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humans
- (2012) Matthias Hoch et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat
- (2012) Michel Alexander Steiner et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Orexin receptor antagonism: an ascending multiple-dose study with almorexant
- (2012) Petra Hoever et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
- (2012) W. J. Herring et al. NEUROLOGY
- Role of Orexin-1 Receptor Mechanisms on Compulsive Food Consumption in a Model of Binge Eating in Female Rats
- (2012) Laura Piccoli et al. NEUROPSYCHOPHARMACOLOGY
- Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep and EEG Power Spectra in a Model of Situational Insomnia
- (2012) Paolo Bettica et al. NEUROPSYCHOPHARMACOLOGY
- Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia
- (2012) Philip L Johnson et al. NEUROPSYCHOPHARMACOLOGY
- Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network
- (2012) Philip L. Johnson et al. PHYSIOLOGY & BEHAVIOR
- Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats
- (2012) Elizabeth A. Lungwitz et al. PHYSIOLOGY & BEHAVIOR
- A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid
- (2012) J. J. Iliff et al. Science Translational Medicine
- The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors
- (2012) Géraldine M. Mang et al. SLEEP
- The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia
- (2012) Paolo Bettica et al. SLEEP
- Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders
- (2011) Romano Di Fabio et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Orexins and their receptors from fish to mammals: A comparative approach
- (2011) Kari K.Y. Wong et al. GENERAL AND COMPARATIVE ENDOCRINOLOGY
- Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist
- (2011) Paolo Bettica et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
- (2011) Christopher J. Winrow et al. NEUROPHARMACOLOGY
- Neuroimaging Evidence of Altered Fronto-Cortical and Striatal Function after Prolonged Cocaine Self-Administration in the Rat
- (2011) Alessandro Gozzi et al. NEUROPSYCHOPHARMACOLOGY
- Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice
- (2011) T. Mochizuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy
- (2011) P.C. Baier et al. SLEEP MEDICINE
- Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system
- (2011) Emily M. Stanley et al. SYNAPSE
- Orexin-1 receptor mediates long-term potentiation in the dentate gyrus area of freely moving rats
- (2010) Esmaeil Akbari et al. BEHAVIOURAL BRAIN RESEARCH
- Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
- (2010) Christopher D. Cox et al. JOURNAL OF MEDICINAL CHEMISTRY
- Differential Effects of the Dual Orexin Receptor Antagonist Almorexant and the GABAA-α1 Receptor Modulator Zolpidem, Alone or Combined with Ethanol, on Motor Performance in the Rat
- (2010) Michel A Steiner et al. NEUROPSYCHOPHARMACOLOGY
- Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder
- (2010) Jeffrey R. Strawn et al. PSYCHONEUROENDOCRINOLOGY
- Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant
- (2010) Hendrik Dietrich et al. PSYCHOPHARMACOLOGY
- Orexins/hypocretins control bistability of hippocampal long-term synaptic plasticity through co-activation of multiple kinases
- (2009) O. Selbach et al. Acta Physiologica
- Regulation of alcohol-seeking by orexin (hypocretin) neurons
- (2009) Andrew J. Lawrence BRAIN RESEARCH
- Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat
- (2009) C. Dugovic et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A key role for orexin in panic anxiety
- (2009) Philip L Johnson et al. NATURE MEDICINE
- Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats
- (2009) Karen E. Boschen et al. PSYCHOPHARMACOLOGY
- Amyloid- Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
- (2009) J.-E. Kang et al. SCIENCE
- I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation
- (2008) N. Ito et al. NEUROSCIENCE
- An essential role for orexins in emergence from general anesthesia
- (2008) M. B. Kelz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disturbed sleep in post-traumatic stress disorder: Secondary symptom or core feature?
- (2008) Victor I. Spoormaker et al. SLEEP MEDICINE REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More